MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$1,941,558
EPS
-$0.18
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenues
---0
General and administrative costs
1,654,031 1,772,400 1,750,658 714,161
Research and development costs
333,376 52,118 50,696 60,648
Total costs and expenses
1,987,407 1,824,518 1,801,354 774,809
Loss from operations
-1,987,407 -1,824,518 -1,801,354 -774,809
Interest income
3,370 2,152 4,430 365
Interest expense
3,096 3,756 457 1,810
Unrealized gain (loss) on digital assets
---182,887 -
Realized loss on digital assets
-568,521* --
Foreign currency gain (loss)
-475 915* -130 -
Other income
-935* --
Foreign currency gain
---581
Net loss
-1,987,608 -2,392,793* --
Net loss attributable to common stockholders
--2,612,967 -1,980,398 -775,673
Series b convertible preferred stock 8 cumulative dividend
-17,882 220,174* -50,367 -
Non-controlling interest
-63,932 ---
Net loss attributable to common stockholders
-1,941,558 --2,030,765 -
Basic EPS
-0.18 --0.33 -0.29
Diluted EPS
-0.18 -0.529 -0.33 -0.29
Basic Average Shares
10,889,003 -6,171,195 2,720,533
Diluted Average Shares
10,889,003 4,840,731* 6,171,195 2,720,533
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$1,941,558 Non-controlling interest-$63,932 Net loss-$1,987,608 (-180.12%↓ Y/Y)Interest income$3,370 (664.17%↑ Y/Y)Series b convertiblepreferred stock 8...-$17,882 Loss from operations-$1,987,407 (-181.13%↓ Y/Y)Interest expense$3,096 (-1.24%↓ Y/Y)Foreign currency gain(loss)-$475 Total costs andexpenses$1,987,407 (181.13%↑ Y/Y)General andadministrative costs$1,654,031 (168.74%↑ Y/Y)Research and developmentcosts$333,376 (264.52%↑ Y/Y)

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)

LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)